nVerses Capital’s Privia Health PRVA Stock Holding History

nVerses Capital’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,500	Closed	-$127K	–	1163
2024 Q1	$127K	Buy	+6,500	New	+$137K	0.31%	128

Other funds holding PRVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

nVerses Capital's PRVA Position: Q2 2024 in Review

nVerses Capital sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 6,500 shares — an estimated $127K sold.

nVerses Capital first reported a position in PRVA in Q1 2024 and held it in 1 quarter. The position peaked at $127K in Q1 2024. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

nVerses Capital reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
nVerses Capital sold 6,500 Privia Health shares in Q2 2024, an estimated $127K.
nVerses Capital first reported a position in Privia Health in Q1 2024 and held it in 1 quarter.
nVerses Capital's Privia Health position peaked at $127K in Q1 2024.
225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.